The company is interested in developing industrial technologies for systems biology. Its endeavours are divided into two parts. Firstly, to adopt open tehcnologies and cast them into accelerator frameworks for enhanced speed and accuracy. Secondly, to develop new technologies in the areas of systems biology. All these technologies are expected to contribute to several areas such as precision and targeted medicine, agriculture, forensics and general research.

The company believes in fast and accurate integration of data across different omics technologies, structural biology and chemoinformatics which forms the key in building new cutting edge systems biology models for applications in diverse domains. These in turn would boost cutting edge applications in healthcare, agriculture and other domains.


  1. S. Natarajan, Krishna Kumar N, D. Pal and S. K. Nandy, "AccuRA: Accurate Alignment of Short Reads on Scalable Reconfigurable Accelerators", Proc. IEEE International Conference on Embedded Computer Systems: Architectures, Modeling and Simulation (SAMOS XVI), pp. 79-87, July 2016.

  2. S. Natarajan, Krishna Kumar N, D. Pal and S. K. Nandy, "Accurate and accelerated secondary analysis of genomes: implications for genomics", Accepted by NGS'17: Structural Variation and Population Genomics.